Literature DB >> 11082191

Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics.

L Smith1, J Novák, J Rocca, S McClung, J D Hillman, A S Edison.   

Abstract

The primary structure of the Streptococcus mutans lantibiotic mutacin 1140 was elucidated by NMR spectroscopy, mass spectrometry, and chemical sequencing. The structure is in agreement with other closely related lantibiotics, such as epidermin. A novel method was developed in which mutacin 1140 was chemically modified with sodium borohydride followed by ethanethiol, allowing the differentiation of the thioether-containing residues from the dehydrated residues. This double-labeling strategy provides a simple method to reliably identify all modified lantibiotic residues with a minimal amount of material. While NMR spectroscopy is still required to obtain thioether bridging patterns and thus the complete covalent structure, the double-labeling technique, along with mass spectrometry, provides most of the information in a fraction of the time required for a complete NMR analysis. Thus, with these new techniques lantibiotics can be rapidly characterized.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082191     DOI: 10.1046/j.1432-1033.2000.01777.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin.

Authors:  Florian Majer; Dietmar G Schmid; Karsten Altena; Gabriele Bierbaum; Thomas Kupke
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

2.  The SapB morphogen is a lantibiotic-like peptide derived from the product of the developmental gene ramS in Streptomyces coelicolor.

Authors:  Shinya Kodani; Michael E Hudson; Marcus C Durrant; Mark J Buttner; Justin R Nodwell; Joanne M Willey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

3.  Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.

Authors:  Máire Begley; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Appl Environ Microbiol       Date:  2009-06-26       Impact factor: 4.792

4.  Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.

Authors:  Jerome Escano; Akshaya Ravichandran; Bita Salamat; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

5.  Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of Clostridium difficile-Associated Infection.

Authors:  Mark E Pulse; William J Weiss; Johan A Kers; Anthony W DeFusco; Jae H Park; Martin Handfield
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

6.  Purification, characterization, and gene sequence of michiganin A, an actagardine-like lantibiotic produced by the tomato pathogen Clavibacter michiganensis subsp. michiganensis.

Authors:  I Holtsmark; D Mantzilas; V G H Eijsink; M B Brurberg
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

7.  Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.

Authors:  Jerome Escano; Byron Stauffer; Jacob Brennan; Monica Bullock; Leif Smith
Journal:  J Bacteriol       Date:  2015-01-20       Impact factor: 3.490

8.  Site-directed mutations in the lanthipeptide mutacin 1140.

Authors:  Shaorong Chen; Shawanda Wilson-Stanford; William Cromwell; Jeffrey D Hillman; Adam Guerrero; Charlotte A Allen; Joseph A Sorg; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2013-04-19       Impact factor: 4.792

Review 9.  Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics.

Authors:  Leif Smith; Jd Hillman
Journal:  Curr Opin Microbiol       Date:  2008-10-24       Impact factor: 7.934

10.  Structural characterization of four prochlorosins: a novel class of lantipeptides produced by planktonic marine cyanobacteria.

Authors:  Weixin Tang; Wilfred A van der Donk
Journal:  Biochemistry       Date:  2012-05-17       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.